The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Organoid Culture Market Research Report 2024
Synopsis
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.
Global Organoid Culture market is projected to reach US$ 352.1 million in 2029, increasing from US$ 103 million in 2022, with the CAGR of 19.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Organoid Culture market research.
The organoid culture market is primarily driven by its potential to revolutionize disease modeling, drug discovery, and personalized medicine. Organoids are three-dimensional miniaturized versions of organs or tissues grown in vitro from stem cells, offering a powerful tool to study human biology and disease mechanisms in a more physiologically relevant context. Their ability to replicate organ-specific functions and responses enables researchers to gain insights into disease pathology and develop more effective and targeted therapies. However, the market also faces challenges, including the complexity and variability of organoid culture protocols, which require optimization and standardization to ensure reproducibility and reliability across research studies and drug development processes. Additionally, ethical considerations related to the use of human-derived stem cells in organoid culture and the potential for organoid models to be misused or overhyped pose ethical and regulatory challenges.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Organoid Culture market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International
Segment by Type
Stem Cell Source
Tumor Cell Source
Segment by Application
Biopharmaceutical Companies
Hospital
Academics and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Organoid Culture report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.
Global Organoid Culture market is projected to reach US$ 352.1 million in 2029, increasing from US$ 103 million in 2022, with the CAGR of 19.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Organoid Culture market research.
The organoid culture market is primarily driven by its potential to revolutionize disease modeling, drug discovery, and personalized medicine. Organoids are three-dimensional miniaturized versions of organs or tissues grown in vitro from stem cells, offering a powerful tool to study human biology and disease mechanisms in a more physiologically relevant context. Their ability to replicate organ-specific functions and responses enables researchers to gain insights into disease pathology and develop more effective and targeted therapies. However, the market also faces challenges, including the complexity and variability of organoid culture protocols, which require optimization and standardization to ensure reproducibility and reliability across research studies and drug development processes. Additionally, ethical considerations related to the use of human-derived stem cells in organoid culture and the potential for organoid models to be misused or overhyped pose ethical and regulatory challenges.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Organoid Culture market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International
Segment by Type
Stem Cell Source
Tumor Cell Source
Segment by Application
Biopharmaceutical Companies
Hospital
Academics and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Organoid Culture report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organoid Culture Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stem Cell Source
1.2.3 Tumor Cell Source
1.3 Market by Application
1.3.1 Global Organoid Culture Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceutical Companies
1.3.3 Hospital
1.3.4 Academics and Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoid Culture Market Perspective (2018-2029)
2.2 Organoid Culture Growth Trends by Region
2.2.1 Global Organoid Culture Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Organoid Culture Historic Market Size by Region (2018-2023)
2.2.3 Organoid Culture Forecasted Market Size by Region (2024-2029)
2.3 Organoid Culture Market Dynamics
2.3.1 Organoid Culture Industry Trends
2.3.2 Organoid Culture Market Drivers
2.3.3 Organoid Culture Market Challenges
2.3.4 Organoid Culture Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organoid Culture Players by Revenue
3.1.1 Global Top Organoid Culture Players by Revenue (2018-2023)
3.1.2 Global Organoid Culture Revenue Market Share by Players (2018-2023)
3.2 Global Organoid Culture Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organoid Culture Revenue
3.4 Global Organoid Culture Market Concentration Ratio
3.4.1 Global Organoid Culture Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organoid Culture Revenue in 2022
3.5 Organoid Culture Key Players Head office and Area Served
3.6 Key Players Organoid Culture Product Solution and Service
3.7 Date of Enter into Organoid Culture Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Organoid Culture Breakdown Data by Type
4.1 Global Organoid Culture Historic Market Size by Type (2018-2023)
4.2 Global Organoid Culture Forecasted Market Size by Type (2024-2029)
5 Organoid Culture Breakdown Data by Application
5.1 Global Organoid Culture Historic Market Size by Application (2018-2023)
5.2 Global Organoid Culture Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Organoid Culture Market Size (2018-2029)
6.2 North America Organoid Culture Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Organoid Culture Market Size by Country (2018-2023)
6.4 North America Organoid Culture Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organoid Culture Market Size (2018-2029)
7.2 Europe Organoid Culture Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Organoid Culture Market Size by Country (2018-2023)
7.4 Europe Organoid Culture Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organoid Culture Market Size (2018-2029)
8.2 Asia-Pacific Organoid Culture Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Organoid Culture Market Size by Region (2018-2023)
8.4 Asia-Pacific Organoid Culture Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organoid Culture Market Size (2018-2029)
9.2 Latin America Organoid Culture Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Organoid Culture Market Size by Country (2018-2023)
9.4 Latin America Organoid Culture Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organoid Culture Market Size (2018-2029)
10.2 Middle East & Africa Organoid Culture Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Organoid Culture Market Size by Country (2018-2023)
10.4 Middle East & Africa Organoid Culture Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Organoid Culture Introduction
11.1.4 Thermo Fisher Scientific Revenue in Organoid Culture Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Organoid Culture Introduction
11.2.4 Merck Revenue in Organoid Culture Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Corning
11.3.1 Corning Company Detail
11.3.2 Corning Business Overview
11.3.3 Corning Organoid Culture Introduction
11.3.4 Corning Revenue in Organoid Culture Business (2018-2023)
11.3.5 Corning Recent Development
11.4 STEMCELL Technologies
11.4.1 STEMCELL Technologies Company Detail
11.4.2 STEMCELL Technologies Business Overview
11.4.3 STEMCELL Technologies Organoid Culture Introduction
11.4.4 STEMCELL Technologies Revenue in Organoid Culture Business (2018-2023)
11.4.5 STEMCELL Technologies Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Organoid Culture Introduction
11.5.4 Lonza Revenue in Organoid Culture Business (2018-2023)
11.5.5 Lonza Recent Development
11.6 Prellis Biologics
11.6.1 Prellis Biologics Company Detail
11.6.2 Prellis Biologics Business Overview
11.6.3 Prellis Biologics Organoid Culture Introduction
11.6.4 Prellis Biologics Revenue in Organoid Culture Business (2018-2023)
11.6.5 Prellis Biologics Recent Development
11.7 amsbio
11.7.1 amsbio Company Detail
11.7.2 amsbio Business Overview
11.7.3 amsbio Organoid Culture Introduction
11.7.4 amsbio Revenue in Organoid Culture Business (2018-2023)
11.7.5 amsbio Recent Development
11.8 Tanwang Medical
11.8.1 Tanwang Medical Company Detail
11.8.2 Tanwang Medical Business Overview
11.8.3 Tanwang Medical Organoid Culture Introduction
11.8.4 Tanwang Medical Revenue in Organoid Culture Business (2018-2023)
11.8.5 Tanwang Medical Recent Development
11.9 Ketu Medicine
11.9.1 Ketu Medicine Company Detail
11.9.2 Ketu Medicine Business Overview
11.9.3 Ketu Medicine Organoid Culture Introduction
11.9.4 Ketu Medicine Revenue in Organoid Culture Business (2018-2023)
11.9.5 Ketu Medicine Recent Development
11.10 Chuangxin International
11.10.1 Chuangxin International Company Detail
11.10.2 Chuangxin International Business Overview
11.10.3 Chuangxin International Organoid Culture Introduction
11.10.4 Chuangxin International Revenue in Organoid Culture Business (2018-2023)
11.10.5 Chuangxin International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
